Get the Stockscreener App
19.38
0.16%
0.03
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $19.38, with a volume of 6.71M.
It is up +0.16% in the last 24 hours and up +15.70% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$19.35
Open:
$19.44
24h Volume:
6.71M
Relative Volume:
0.83
Market Cap:
$10.01B
Revenue:
$11.32B
Net Income/Loss:
$-981.00M
P/E Ratio:
-9.9222
EPS:
-1.9532
Net Cash Flow:
$714.00M
1W Performance:
+3.19%
1M Performance:
+15.70%
6M Performance:
+4.53%
1Y Performance:
-35.72%
1-Day Range:
$19.32
$19.75
1-Week Range:
$18.11
$19.75
52-Week Range:
$15.73
$32.04
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
19.38 | 9.99B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
422.06 | 148.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
151.16 | 41.21B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.81 | 32.47B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
196.04 | 28.19B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.61 | 29.13B | 29.14B | 1.07B | 1.05B | 1.1956 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
FMR LLC holds 10.3% of Baxter (NYSE: BAX) — 52.97M shares disclosed - Stock Titan
Is It Too Late to Buy Baxter International Inc (BAX) After 4.4% Rally? GF Value Says Undervalued - GuruFocus
Baxter International Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Baxter (BAX) interim CFO Anita Zielinski receives 13,426-share equity grant - Stock Titan
Baxter (BAX) surgery president forfeits shares to cover RSU tax bill - Stock Titan
Baxter (BAX) executive forfeits 321 shares to cover RSU tax withholding - Stock Titan
Baxter Introduces IV Verify Line Labeling System - Medical Product Outsourcing
Baxter Highlights Recent Sustainable Activities and Recognition - CSRwire
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International Inc. stock (US0673431090): Shares ease around USD 18 after recent earnings and - AD HOC NEWS
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter International Inc. (BAX) Stock Analysis: Navigating the Healthcare Sector with a 14.71% Potential Upside - DirectorsTalk Interviews
Baxter International Inc. stock (US0673431090): shares steady on NYSE as investors watch technical s - AD HOC NEWS
Baxter and Its Foundation Contribute Nearly $44 Million in 2008 to Address Critical Needs Locally and Globally - CSRwire
Baxter International Inc. stock (US0673431090): shares trade near lower end of 52-week range on NYSE - AD HOC NEWS
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
symbol__ Stock Quote Price and Forecast - CNN
Baxter International (NY: BAX - FinancialContent
Why Baxter (BAX) Shares Are Sliding Today - Yahoo Finance
Baxter International Inc.: - marketscreener.com
Citi Downgrades Baxter International Inc(BAX.US) to Sell Rating, Cuts Target Price to $17 - Moomoo
Citigroup Downgrades Baxter International to Sell From Neutral, Adjusts PT to $17 From $19 - Moomoo
Baxter International Inc To Go Ex-Dividend On May 29th, 2026 With 0.01 USD Dividend Per Share - 富途牛牛
Baxter International Stock Surges 12%, With A 6-Day Winning Spree - Trefis
Baxter International Stock 6-Day Winning Spree: Stock Climbs 12% - Trefis
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare’s Dynamic Terrain with 15% Upside Potential - DirectorsTalk Interviews
Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump - Yahoo Finance
Baxter Stock Logs Worst Day In 3 Months On Margin Pain And Weak Guidance — Retail Sees Long-Term Buy Opportunity - MSN
5-Day Rally Sends Baxter International Stock Up 11% - Trefis
Baxter International Stock 5-Day Winning Spree: Stock Climbs 11% - Trefis
Baxter International Inc (BAX) Stock Price, Quote, News & History - Benzinga
Baxter Highlights Social, Economic and Environmental Performance in Seventh Annual Sustainability Report - CSRwire
Baxter Stock Is Testing a Bottom After Healthcare Sector Decimation - Yahoo Finance
Market Watch Rx: Baxter International Leads Gainers - Pharmaceutical Executive
Why Baxter Gains as Russell 1000 Index Healthcare Shift Trend? - Kalkine Media
Q1 Earnings Review: Medical Devices & SuppliesDiversified Stocks Led by Baxter (NYSE:BAX) - Yahoo Finance UK
Baxter International Inc. stock (US0673431090): spin-off hangover meets margin push - AD HOC NEWS
Baxter International earnings preview: What to expect - MSN
Baxter International shareholders approve board slate, pay and incentive plan at annual meeting - MSN
First Pacific Advisors's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Inc. stock (US0673431090): governance changes and board size reset in focus - AD HOC NEWS
Baxter International Inc. stock (US0673431090): spin-off hangover meets restructuring push - AD HOC NEWS
Baxter International Inc (BAX) Stock Up 3.0% and Still Undervalued -- GF Score: 61/100 - GuruFocus
Baxter Board Size Reset Puts Governance Changes In Focus For Investors - simplywall.st
Baxter stock (US0673431090): FDA update puts focus on hospital-device demand - AD HOC NEWS
TD Cowen Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $20 - Moomoo
BAX (NYSE: BAX) affiliate files notice listing prior open-market purchases - Stock Titan
Baxter International Inc. (BAX) Stock Analysis: Exploring a 27.83% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Is Baxter International (BAX) Pricing Reflect A Turn After Steep Multi Year Share Price Declines - Sahm
Baxter hosts manufacturing forum - Manufacturers' Monthly
Baxter International stock (US0673431090): News flow turns after fresh market moves - AD HOC NEWS
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.33%
8.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):